Back to Report Store Home

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

  • Published: Apr-2018
  • Report Code: GBIHC471MR
  • Report Format: pdf

Description

List of Tables

Table 1: Type 2 Diabetes Mellitus, Global, Related Indications of T2DM First-in-Class Products, 2018 40

Table 2: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 44

Table 3: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 44

Table 4: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 45

Table 5: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 46

Table 6: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 47

Table 7: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 47

Table 8: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 47

Table 9: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 48

Table 10: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 48

Table 11: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 49

Table 12: Type 2 Diabetes Mellitus Drugs Market, Global, Pipeline Programs Targeting XXX, 2018 49

Table 13: Type 2 Diabetes Mellitus Drugs Market, Global, Pipeline Programs Targeting XXX , 2018 50

Table 14: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 51

Table 15: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 51

Table 16: Type 2 Diabetes Mellitus, Global, Global, Pipeline Programs Targeting XXX, 2018 51

Table 17: Type 2 Diabetes Mellitus Drugs Market, Global, Key Features of Targeting XXX, 2018 52

Table 18: Type 2 Diabetes Mellitus Drugs Market, Global, Pipeline Programs Targeting XXX, 2018 52

Table 19: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 53

Table 20: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 53

Table 21: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 54

Table 22: Type 2 Diabetes Mellitus, Global, Key Features of XXX, 2018 55

Table 23: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 55

Table 24: Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting XXX, 2018 55

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards